NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 194 filers reported holding NEVRO CORP in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,789,000 | +57.8% | 31,379 | +139.8% | 1.65% | +16.6% |
| Q1 2018 | $1,134,000 | -30.9% | 13,087 | -45.0% | 1.42% | -36.4% |
| Q4 2017 | $1,642,000 | +53.0% | 23,785 | +101.5% | 2.23% | +79.2% |
| Q3 2017 | $1,073,000 | -76.3% | 11,804 | -80.6% | 1.24% | -76.9% |
| Q2 2017 | $4,532,000 | +77.0% | 60,893 | +122.9% | 5.37% | +50.6% |
| Q1 2017 | $2,560,000 | +22.7% | 27,318 | -4.9% | 3.57% | -8.0% |
| Q4 2016 | $2,087,000 | +64.5% | 28,725 | +136.2% | 3.88% | +75.8% |
| Q3 2016 | $1,269,000 | -66.0% | 12,161 | -76.0% | 2.21% | -67.7% |
| Q2 2016 | $3,735,000 | +34.4% | 50,633 | +2.5% | 6.84% | -5.5% |
| Q1 2016 | $2,778,000 | -25.1% | 49,377 | -10.1% | 7.24% | +29.2% |
| Q4 2015 | $3,708,000 | +29.7% | 54,927 | -10.9% | 5.61% | -12.0% |
| Q3 2015 | $2,860,000 | – | 61,660 | – | 6.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |